You are not currently logged in.
Access JSTOR through your library or other institution:
The Economic Effect of Screening Orthopedic Surgery Patients Preoperatively for Methicillin‐Resistant Staphylococcus aureus
Bruce Y. Lee , MD, MBA, Ann E. Wiringa , MPH, Rachel R. Bailey , MPH, Vishal Goyal , MPH, Becky Tsui , MPH, G. Jonathan Lewis , DO, MPH, Robert R. Muder , MD and Lee M. Harrison , MD
Infection Control and Hospital Epidemiology
Vol. 31, No. 11 (November 2010), pp. 1130-1138
Published by: Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
Stable URL: http://www.jstor.org/stable/10.1086/656591
Page Count: 9
You can always find the topics here!Topics: Staphylococcus aureus, Decolonization, Surveillance, Infections, Orthopedic surgery, Economic value, Health outcomes, Statistical median, Orthopedic procedures, Patient surveillance
Were these topics helpful?See something inaccurate? Let us know!
Select the topics that are inaccurate.
Preview not available
Background and objective. Patients undergoing orthopedic surgery are susceptible to methicillin‐resistant Staphylococcus aureus (MRSA) infections, which can result in increased morbidity, hospital lengths of stay, and medical costs. We sought to estimate the economic value of routine preoperative MRSA screening and decolonization of orthopedic surgery patients. Methods. A stochastic decision‐analytic computer simulation model was used to evaluate the economic value of implementing this strategy (compared with no preoperative screening or decolonization) among orthopedic surgery patients from both the third‐party payer and hospital perspectives. Sensitivity analyses explored the effects of varying MRSA colonization prevalence, the cost of screening and decolonization, and the probability of decolonization success. Results. Preoperative MRSA screening and decolonization was strongly cost‐effective (incremental cost‐effectiveness ratio less than $6,000 per quality‐adjusted life year) from the third‐party payer perspective even when MRSA prevalence was as low as 1%, decolonization success was as low as 25%, and decolonization costs were as high as $300 per patient. In most scenarios this strategy was economically dominant (ie, less costly and more effective than no screening). From the hospital perspective, preoperative MRSA screening and decolonization was the economically dominant strategy for all scenarios explored. Conclusions. Routine preoperative screening and decolonization of orthopedic surgery patients may under many circumstances save hospitals and third‐party payers money while providing health benefits.
© 2010 by The Society for Healthcare Epidemiology of America. All rights reserved.